Author Page for Lia Supino-Rosin

Actions:

View:
Selected
Original List
All Versions Hide All Versions
All Abstracts Hide All Abstracts

(Rank)

Robust Antibody Response after a Third BNT162b2 Vaccine Compared to the Second Among Immunocompromised and Healthy Individuals, a Prospective Longitudinal Cohort Study

Number of pages: 30 Posted: 19 Mar 2022

Shirley Shapiro Ben David, Barak Mizrahi, Daniella Rahamim-Cohen, Lia Supino-Rosin, Arnon Shahar, Sharon Hermoni-Alon, Ariela Fremder Sacerdote, Angela Irony, Rachel Lazar, Nir Kalkstein, Yaniv Lustig, Victoria Indenbaum, Daniel Landsberger, Miri Mizrahi-Reuveni and Shirley Shapira

Maccabi HealthCare Services, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, KI Research Institute, Chaim Sheba Medical Center - Central Virology Laboratory, Chaim Sheba Medical Center - Central Virology Laboratory, affiliation not provided to SSRN, Maccabi HealthCare Services and Maccabi HealthCare Services

Downloads 35 (1,249,711)

Lia Supino-Rosin

affiliation not provided to SSRN

1

35

0

Scholarly Papers (1)

Robust Antibody Response after a Third BNT162b2 Vaccine Compared to the Second Among Immunocompromised and Healthy Individuals, a Prospective Longitudinal Cohort Study

Abstract: